Physicians' Academy for Cardiovascular Education

CETP Modulation

Slides (presentation) - Mar. 25, 2011

New approaches to CETP modulation

View teaching slides on mechanisms and clinical trials with CETP modulators


New Approaches to HDL modification
The Inhibition of Cholesterol Ester Transfer Protein
CETP Levels and CAD risk:
Rationale
RADIANCE 1 and 2
RADIANCE 1
RADIANCE 2
RADIANCE 1- Heterozygous FH Adverse Events (All Causality)
ILLUMINATE
ILLUMINATE
On Trial Lipid Levels By Study Month
Primary Endpoint ILLUMINATE:
Differences Between CETP inhibitors
CETP Inhibitors
Comparison of CETP Inhibitors
Dalcetrapib
Phase II trials with Dalcetrapib
Phase II trials with Dalcetrapib
The Dal-HEART Program

Share this page with your colleagues and friends: